Montreal Cancer Consortium (MCC)
Montreal Cancer Consortium (MCC)
Montreal Cancer Consortium (MCC)
Montreal Cancer Consortium (MCC)

The multiple organizations supporting this initiative, including Oncopole, will contribute a total of $6.5 million to the Montreal Cancer Consortium over the next two years. As the project catalyst, TFRI is providing $2 million.

The MCC researchers will pursue their work toward improving treatments for cancer patients through precision and personalized medicine.

The MCC comprises many institutions: the Centre de recherche du Centre hospitalier de l’Université de Montréal (CRCHUM), the Goodman Cancer Research Centre (GCRC), the Centre de Recherche de l’Hôpital Maisonneuve-Rosemont (CR-HMR), the Institute for Research in Immunology and Cancer (IRIC), the Jewish General Hospital (JGH), McGill University, the Université de Montréal, Génome Québec Innovation Centre, and the Research Institute of the McGill University Health Centre (RI-MUHC).

More specifically, Oncopole supports the following project:

Inter-institutional coordination and integration of clinical data and biospecimens from patients treated through the Montreal Cancer Consortium.

This project is set to create and integrate harmonized tissue biobanking throughout the various MCC institutions. In this pilot project, priority will be given to cancers that benefit significantly from immunotherapy as a therapeutic approach while ensuring that biobanks meet registration and certification criteria. Tissues collected must also help meet the needs of other MCC projects.

This project will also enable all MCC members to use the ATiM, a Biobank Information Management System (BIMS) from the Canadian Tissue Repository Network (http://www.ctrnet.ca/resources/atim).

For this project, the consortium will count on the proven expertise of the following partners: the Cancer Research Network (RRCancer), the Canadian Tissue Repository Network (CTRNet) and Exactis Innovation (Exactis).

Principal Researchers

Morag Park
Goodman Cancer Research Centre
Anne-Marie Mes-Masson
Centre de recherche du CHUM
Wilson Miller
Jewish General Hospital
Gerald Batist
Jewish General Hospital
George Zogopoulos
McGill University Health Centre (MUHC)
Josée Hébert
Hôpital Maisonneuve-Rosemont

Co-applicants & Users

Saima Hassan
CHUM
John Stagg
CHUM
Simon Turcotte
CHUM
Rahima Jamal
CHUM
Karl Bélanger
CHUM
Moishe Lieberman
CHUM
Norman Blais
CHUM
Sonia Cellot
CHU Sainte-Justine
David Mitchell
Centre hospitalier de Montréal pour enfants - CUSM
Jean-Sébastien Delisle
Hôpital Maisonneuve-Rosemont
Mark Basik
Jewish General Hospital
Alan Spatz
Jewish General Hospital
Sarit Assouline
Jewish General Hospital
Jason Agulnik
Jewish General Hospital
Cristiano Ferrario
Jewish General Hospital
Jennifer Friedman
Jewish General Hospital
François Patenaude
Jewish General Hospital
Ari Meguerditchian
MUHC
Sarkis Meterissian
MUHC
Catalin Mihalcioiu
MUHC
Jonathan Spicer
MUHC
Beatrice Wang
MUHC
Kevin Watters
MUHC
Summary
Oncopole contribution
$750,000